Abstract
Purpose of Review
Obstructive sleep apnea (OSA) is characterized by repetitive episodes of complete or partial upper airway obstruction during sleep. Studies indicate that OSA is an independent risk factor for cognitive decline in older patients. The purpose of this paper is to critically review the recent literature on the cognitive effects of untreated OSA and the benefits of treatment across cognitive domains.
Recent Findings
OSA’s greatest impact appears to be on attention, vigilance, and information processing speed. Furthermore, the presence of OSA seems to have a significant impact on development and progression of mild cognitive impairment (MCI). Impact of OSA treatment, particularly with CPAP, appears to mitigate and slow the rate of cognitive decline and may reduce the risk of dementia.
Summary
Larger properly controlled studies, of a prospective nature, are required to further elucidate the degree of treatment effect. More studies are needed on other treatments for OSA such as oral mandibular devices and hypoglossal nerve stimulation.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687–98. https://doi.org/10.1016/S2213-2600(19)30198-5.
Patel SR. Obstructive sleep apnea. Ann Intern Med. 2019;171:ITC81–96. https://doi.org/10.7326/AITC201912030.
Semelka M, Wilson J, Floyd R. Diagnosis and treatment of obstructive sleep apnea in adults. Am Fam Physician. 2016;94:355–60.
Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020;323:1389–400. https://doi.org/10.1001/jama.2020.3514.
Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest. 1997;99:106–9.
Peppard P, Young T, Palta M, Skatrud J. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84.
Lavie P, Here P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension. BMJ. 2000;320:479–82.
Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30:633–46.
Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383:736–47. https://doi.org/10.1016/S0140-6736(13)60734-5.
Gami AS, Olson EJ, Shen WK, Wright RS, Ballman KV, Hodge DO, et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol. 2013;62:610–6. https://doi.org/10.1016/j.jacc.2013.04.080.
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–41. https://doi.org/10.1056/NEJMoa043104.
Garbarino S, Bardwell WA, Guglielmi O, Chiorri C, Bonanni E, Magnavita N. Association of anxiety and depression in obstructive sleep apnea patients: a systematic review and meta-analysis. Behav Sleep Med. 2020;18:35–57. https://doi.org/10.1080/15402002.2018.1545649.
Emamian F, Khazaie H, Tahmasian M, Leschziner GD, Morrell MJ, Hsiung GY, et al. The association between obstructive sleep apnea and Alzheimer's disease: a meta-analysis perspective. Front Aging Neurosci. 2016;8:78. https://doi.org/10.3389/fnagi.2016.00078.
Seda G, Han TS. Effect of obstructive sleep apnea on neurocognitive performance. Sleep Med Clin. 2020;15:77–85. https://doi.org/10.1016/j.jsmc.2019.10.001.
Prabhakar NR, Peng YJ, Nanduri J. Hypoxia-inducible factors and obstructive sleep apnea. J Clin Invest. 2020;130:5042–51. https://doi.org/10.1172/JCI137560This paper reviews the role of intermittent hypoxia in vascular disease, metabolic disease, and cognitive impairment.
Alomri RM, Kennedy GA, Wali SO, Ahejaili F, Robinson SR. Differential associations of hypoxia, sleep fragmentation and depressive symptoms with cognitive dysfunction in obstructive sleep apnoea. Sleep. . https://doi.org/10.1093/sleep/zsaa213.
Liu S, Shen J, Li Y, Wang J, Wang J, Xu J, et al. EEG power spectral analysis of abnormal cortical activations during REM/NREM sleep in obstructive sleep apnea. Front Neurol. 2021. https://doi.org/10.3389/fneur.2021.643855.
Zhu X, Zhao Y. Sleep-disordered breathing and the risk of cognitive decline: a meta-analysis of 19,940 participants. Sleep Breath. 2018;22:165–73. https://doi.org/10.1007/s11325-017-1562-xMeta-analysis of cohort studies to evaluate the association between SDB and cognitive decline. SDB may be an independent risk factor for the developing of cognitive decline, and gender difference may exist regarding this association.
Mubashir T, Abrahamyan L, Niazi A, Piyasena D, Arif AA, Wong J, et al. The prevalence of obstructive sleep apnea in mild cognitive impairment: a systematic review. BMC Neurol. 2019;19:195. https://doi.org/10.1186/s12883-019-1422-3.
Caporale M, Palmeri R, Corallo F, Muscarà N, Romeo L, Bramanti A, et al. Cognitive impairment in obstructive sleep apnea syndrome: a descriptive review. Sleep Breath. 2021;25:29–40. https://doi.org/10.1007/s11325-020-02084-3.
Beaudin AE, Raneri JK, Ayas NT, Skomro RP, Fox N, Hirsch Allen AM, et al. Cognitive function in a sleep clinic cohort of patients with obstructive sleep apnea. Ann Am Thorac Soc. 2020. https://doi.org/10.1513/AnnalsATS.202004-313OCThis study found that cognitive impairment is highly prevalent in patients referred to sleep clinics for suspected OSA, occurring predominantly in older males with moderate-to-severe OSA and concurrent vascular comorbidities. Moderate-to-severe OSA is an independent risk factor for MCI.
Olaithe M, Bucks RS. Executive dysfunction in OSA before and after treatment: a meta-analysis. Sleep. 2013;36:1297–305. https://doi.org/10.5665/sleep.2950.
Suchy Y. Executive functioning: overview, assessment, and research issues for non-neuropsychologists. Ann Behav Med. 2009;37:106–16.
Fisk JE, Sharp CA. Age-related impairment in executive functioning: updating, inhibition, shifting, and access. J Clin Exp Neuropsychol. 2004;26:874–90.
Adrover-Roig D, Sesé A, Barceló F, Palmer A. A latent variable approach to executive control in healthy ageing. Brain Cogn. 2012;78:284–99. https://doi.org/10.1016/j.bandc.2012.01.005.
Angelelli P, Macchitella L, Toraldo DM, Abbate E, Marinelli CV, Arigliani M, et al. The neuropsychological profile of attention deficits of patients with obstructive sleep apnea: an update on the daytime attentional impairment. Brain Sci. 2020;10:325. https://doi.org/10.3390/brainsci10060325This study compared moderate to severe OSA patients matched to healthy controls on attention and vigilance. Patients with severe OSA and severe hypoxemia underperformed on alertness and vigilance attention subtests.
Huang Y, Hennig S, Fietze I, Penzel T, Veauthier C. The psychomotor vigilance test compared to a divided attention steering simulation in patients with moderate or severe obstructive sleep apnea. Nat Sci Sleep. 2020;12:509–24. https://doi.org/10.2147/NSS.S256987.
Shen YC, Kung SC, Chang ET, Hong YL, Wang LY. The impact of obesity in cognitive and memory dysfunction in obstructive sleep apnea syndrome. Int J Obes. 2019;43:355–61. https://doi.org/10.1038/s41366-018-0138-6.
McCloy K, Duce B, Swarnkar V, Hukins C, Abeyratne U. Polysomnographic risk factors for vigilance-related cognitive decline and obstructive sleep apnea. Sleep Breath. 2021;25:75–83. https://doi.org/10.1007/s11325-020-02050-z.
Duce B, Kulkas A, Töyräs J, Terrill P, Hukins C. Longer duration electroencephalogram arousals have a better relationship with impaired vigilance and health status in obstructive sleep apnoea. Sleep Breath. 2021;25:263–70. https://doi.org/10.1007/s11325-020-02110-4.
Sivam S, Poon J, Wong KKH, Yee BJ, Piper AJ, D'Rozario AL, et al. Slow-frequency electroencephalography activity during wake and sleep in obesity hypoventilation syndrome. Sleep. 2020;43:zsz214. https://doi.org/10.1093/sleep/zsz214This study showed that patients with OHS have greater slow frequency EEG activity during sleep and wake than equally obese patients with OSA. Greater EEG slowing was associated with worse vigilance and lower oxygenation during sleep.
Kushida CA, Nichols DA, Holmes TH, Quan SF, Walsh JK, Gottlieb DJ, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the apnea positive pressure long-term efficacy study (APPLES). Sleep. 2012;35:1593–602. https://doi.org/10.5665/sleep.2226The APPLES study was a 6-month, randomized, double-blind, 2-arm, sham-controlled, multicenter trial conducted at 5 U.S. university, hospital, or private practices. Of 1,516 participants enrolled, 1,105 were randomized, and 1,098 participants diagnosed with OSA contributed to the analysis of the primary outcome measures. CPAP treatment improved both subjectively and objectively measured sleepiness, especially in individuals with severe OSA (AHI > 30).
Wang ML, Wang C, Tuo M, Yu Y, Wang L, Yu JT, et al. Cognitive effects of treating obstructive sleep apnea: a meta-analysis of randomized controlled trials. J Alzheimers Dis. 2020;75:705–15. https://doi.org/10.3233/JAD-200088.
Bhat S, Gupta D, Akel O, Polos PG, DeBari VA, Akhtar S, et al. The relationships between improvements in daytime sleepiness, fatigue and depression and psychomotor vigilance task testing with CPAP use in patients with obstructive sleep apnea. Sleep Med. 2018;49:81–9. https://doi.org/10.1016/j.sleep.2018.06.012.
Turner K, Zambrelli E, Lavolpe S, Baldi C, Furia F, Canevini MP. Obstructive sleep apnea: neurocognitive and behavioral functions before and after treatment. Funct Neurol. 2019;34(2):71–8.
Dostálová V, Kolečkárová S, Kuška M, Pretl M, Bezdicek O. Effects of continuous positive airway pressure on neurocognitive and neuropsychiatric function in obstructive sleep apnea. J Sleep Res. 2019;28:e12761. https://doi.org/10.1111/jsr.12761.
Dunietz GL, Chervin RD, Burke JF, Conceicao AS, Braley TJ. Obstructive sleep apnea treatment and dementia risk in older adults. Sleep. 2021. https://doi.org/10.1093/sleep/zsab076This large retrospective study utilized Medicare 5% fee-for-service claims data of 53,321 beneficiaries, aged 65+, with an OSA diagnosis to examine associations between PAP therapy, adherence and incident diagnoses of Alzheimer's disease (AD), mild cognitive impairment (MCI), and dementia not-otherwise-specified (DNOS) in older adults. PAP treatment and adherence were independently associated with lower odds of incident AD diagnoses in older adults. Results suggest that treatment of OSA may reduce risk of subsequent dementia. Lower odds of MCI, approaching statistical significance, were also observed among PAP users.
Wang Y, Cheng C, Moelter S, Fuentecilla JL, Kincheloe K, Lozano AJ, et al. One year of continuous positive airway pressure adherence improves cognition in older adults with mild apnea and mild cognitive impairment. Nurs Res. 2020;69:157–64. https://doi.org/10.1097/NNR.0000000000000420.
Richards KC, Gooneratne N, Dicicco B, Hanlon A, Moelter S, Onen F, et al. CPAP adherence may slow 1-year cognitive decline in older adults with mild cognitive impairment and apnea. J Am Geriatr Soc. 2019;67:558–64. https://doi.org/10.1111/jgs.15758.
Skiba V, Novikova M, Suneja A, McLellan B, Schultz L. Use of positive airway pressure in mild cognitive impairment to delay progression to dementia. J Clin Sleep Med. 2020;16:863–70. https://doi.org/10.5664/jcsm.8346.
Enciso R. Effects of CPAP and mandibular advancement device treatment in obstructive sleep apnea patients: a systematic review and meta-analysis. Sleep Breath. 2018;22:555–68. https://doi.org/10.1007/s11325-017-1590-6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors have nothing to disclose.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors
Disclaimer
The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the US Government.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Sleep
Rights and permissions
About this article
Cite this article
Seda, G., Matwiyoff, G. & Parrish, J.S. Effects of Obstructive Sleep Apnea and CPAP on Cognitive Function. Curr Neurol Neurosci Rep 21, 32 (2021). https://doi.org/10.1007/s11910-021-01123-0
Accepted:
Published:
DOI: https://doi.org/10.1007/s11910-021-01123-0